Nucleolar localization of TERT is unrelated to telomerase function in human cells

Journal of Cell Science

Volumn 121, Issue 13, 2008, Pages 2169-2176

  Lin, Jian ^a   Jin, Rui ^a   Zhang, Bin ^a   Chen, Hao ^a   Bai, Yun Xiu ^a   Yang, Ping Xun ^a   Han, Su Wen ^a   Xie, Yao Hua ^a   Huang, Pei Tang ^a   Huang, Cuifen ^a   Huang, Jun Jian ^a  

^a BEIJING INSTITUTE OF BIOTECHNOLOGY   (China)

Author keywords

Localization; NTS; Nucleolus; Telomerase; TERT

Indexed keywords

TELOMERASE; TELOMERASE REVERSE TRANSCRIPTASE;

ANIMAL CELL; ARTICLE; CANCER CELL; CELL NUCLEUS; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME INACTIVATION; ENZYME LOCALIZATION; FIBROBLAST; GENE MUTATION; HUMAN; HUMAN CELL; MOUSE; MUTATIONAL ANALYSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN TARGETING; PROTEIN TRANSPORT; TELOMERE; WILD TYPE;

AMINO ACID SEQUENCE; ANIMALS; CATALYTIC DOMAIN; CELL LINE; CELL NUCLEOLUS; HUMANS; MICE; NUCLEAR LOCALIZATION SIGNALS; RIBONUCLEOPROTEINS; RNA; SEQUENCE HOMOLOGY, AMINO ACID; TELOMERASE; TELOMERE;

EID: 48049088130     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: 10.1242/jcs.024091     Document Type: Article

References (33)

1. Aisner, D. L., Wright, W. E. and Shay, J. W. (2002). Telomerase regulation: not just flipping the switch. Curr. Opin. Genet. Dev. 12, 80-85.
2. Blackburn, E. H. (2005). Telomeres and telomerase: their mechanisms of action and the effects of altering their functions. FEBS Lett. 579, 859-862.
3. Bodnar, A. G., Ouellette, M., Frolkis, M., Holt, S. E., Chia, C. P., Morin, G. B., Harley, C. B., Shay, J. W., Lichtseiner, S. and Wright, W. E. (1998). Extension of life-span by introduction of telomerase into normal human cells. Science 279, 349-352.
4. Chen, Y., Lin, M. C., Yao, H., Wang, H., Zhang, A. Q., Ya, J., Hui, C. K., Lau, G. K., He, M. L., Sung, J. et al. (2007). Lentivirus-mediated RNA interference targeting enchancer of zeste homolog 2 inhibits hepatocellular carcinoma growth through down-regulation of stathmin. Hepatology 46, 200-208.
5. Dez, C., Henras, A., Faucon, B., Lafontaine, D., Caizergues-Ferrer, M. and Henry, Y. (2001). Stable expression in yeast ofthe mature form of human telomerase RNA depends on its association with the box H/ACA small nucleolar RNP proteins Cbf5p, Nhp2p and Nop10p. Nucleic Acids Res. 29, 598-603.
6. Etheridge, K. T., Banik S. S., Armbruster, B. N., Zhu, Y., Terns IL M., Terns, M. P. and Counter, C. M. (2002). The nucleolar localization domain of the catalytic subunit of human telomerase. J. Biol. Chem. 277, 24764-24770.
7. Feng, J., Funk, W. D., Wang, S. S., Weinrich, S. L, Avilion, A. A., Chia, C. P., Adams, R. R., Chang, E., Allsopp, R. C., Yu, J. et al. (1995). The RNA component of human telomerase. Science 269, 1236-1241.
8. Fu, W., Begley, J. G., Killen, M. W. and Mattson, M. P. (1999). Anti-apoptotic role of telomerase in pheochromocytonia cells. J. Biol. Chem. 274, 7264-7271.
9. Hahn, W. C., Counter, C. M., Lundberg, A. S., Beijersbergen, R. L., Brooks, M. W. and Weinberg, R. A. (1999). Creation of human tumor cells with defined genetic elements. Nature 400, 464-468.
10. Hatanaka, M. (1990). Discovery of the nucleolar targeting signal. Bioessays 12, 143-148.
11. Hathcock, K. S., Jeffrey, C. Y. and Hodes, R. J. (2005). In vivo regulation of telomerase activity and telomere length. Immunol. Rev. 205, 104-113.
12. Hayflick, L. (1973). The biology of human aging. Am. J. Med. Sci. 265, 675-681.
13. Horky, M., Kotala, V., Anton, M. and Wesierska-Gadek, J. (2002). Nucleolus and apoptosis. Ann. N. Y. Acad. Sci. 973, 258-264.
14. Huang, J. J., Lin, M. C., Bai, Y. X., Jing D. D., Wong, B. C., Han, S. W., Lin, J., Xu, B., Huang, C. F. and Kung, H. F. (2002). Ectopic expression ofa COOH-terminal fragment of the human telomerase reverse transcriptase leads to telomere dysfunction and reduction of growth and tumorigenicity in HeLa cells. Cancer Res. 62, 3226-3232.
15. Huang, J., Bai, Y. X., Han, S. W., Ng, S. S., Jing, D, Wong, B. C, Huang, C. F., Kung, H. F. and Lin, M. C. (2003). A human TERT C-terminal polypeptide sensitizes HeLa cells to H202-induced senescence without affecting telomerase enzymatic activity. Biochem. Biophys. Res. Commun. 301, 627-632.
16. Kim, N. W. and Wu, F. (1997). Advances in quantification and characterization of telomerase activity by the telomeric repeat amplification protocol (TRAP). Nucleic Acids Res. 25, 2595-2597.
17. Kim, N. W., Piatyzszek, M. A., Prowse, K. R., Harley, C. B., West, M. D., Ho, P. L., Coviello, G. M., Weinrich, S. L. and Shay, J. W. (1994). Specific association of human telomerase activity with immortal cells and cancer. Science 266, 2011-2015.
18. Lin, J. and Blackburn, E. H. (2004). Nucleolar protein PinX1p regulates telomerase by sequestering its protein catalytic subunit in an inactive complex lacking telomerase RNA. Genes Dev. 18, 387-396.
19. Lin, S. Y. and Elledge, S. C. (2003). Multiple tumor suppressor pathways negatively regulate telomerasse. Cell 113, 881-889.
20. Masutomi, K., Yu, E. Y., Khurts, S., Ben-Porath, L, Currier, J. L., Metz, G. B, Brooks, M. W., Kaneko, S., Murakami, S., DeCaprio, J. A. et al. (2003). Telomerase maintains telomere structure in normal human cells. Cell 114, 241-253.
21. Meyerson, M. J., Counter, C. M., Eaton, E. N., Ellisen, L. W., Steiner, P., Caddle, S. D., Ziaugra, L., Beijersbergen, R., L., Davidoff, M. J., Liu, Q. et al. (1997). hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in human tumor cells and during immortalization. Cell 90, 785-795.
22. Mitchell, J. PL, Wood, E. and Collins, K. (1999). A telomerase component is defective in the human disease dyskeratosis congenita. Nature 402, 551-555.
23. Parkinson, K. (2005). Telomerase as a target for cancer therapy. Curr. Opin. Investig. Drugs 6, 605-610.
24. Pogacic, V., Dragon, F. and Filipowicz, W. (2000). Human H/ACA small nucleolar RNPs and telomerase share evolutionarily conserved proteins NHP2 and N0P10. Mol. Cell. Biol. 20, 9028-9040.
25. Rahman, PL, Latonen, L. and Wiman, K. G. (2005). hTERT antagonizes p53-induced apoptosis independently of telomerase activity. Oncogene 24, 1320-1327.
26. Stewart, S. A. and Weinberg, R. A. (2000). Telomerase and human tumorigenesis. Semin. Cancer Biol. 10, 399-406.
27. Stewart, S. A., Hahn, W. C., O'Connor, B. F., Banner, E. N., Lundberg, A. S., Modba, P., Mizuno, H., Brooks, M. W., Fleming, M., Zimonjic, D. B. et al. (2002). Telomerase contributes to tumorigenesis by a telomere length-independent mechanism. Proc Natl Acad Sci. USA, 99, 12606-12611.
28. Tomlinson, R. L., Ziegler, T. D., Supakorndej, T., Terns, R. M. and Terns, M. P. (2006). Cell cycle-regulated trafficking of human telomerase to telomeres. Mol. Biol. Cell 17, 955-965.
29. Wang, Y., Blandino, G. and Givol, D. (1999). Induced p21waf expression in H1299 cell line promotes cell senescence and protects against cytotoxic effect of radiation and doxorubicin. Oncogene 18, 2643-2649.
30. Wang, J. M., Kusdra, L. and Collins, K. (2002). Subcellular shuttling of human telomerase induced by transformation and DNA damage. Nat. Cell Biol. 4, 731-736.
31. Yang, Y., Chen, Y., Zhang, C., Huang, H. and Weissman, S. M. (2002). Nucleolar localization of hTERT protein is associated with telomerase function. Exp. Cell Res. 277, 201-209.
32. Ye, K. (2005). Nucleophosmin/B23, a multifunctional protein that can regulate apoplosis. Cancer Biol. Ther. 96, 463-472.
33. Zhu, Y., Tomlinson, R. L., Lukowiak, A. A., Terns, R. M. and Terns, M. F. (2004). Telomerase RNA accumulates in Cajal bodies in human cancer cells. Mol. Biol. Cell 15, 81-90.